Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction - Test2 - elhamkhani - TriplyDB

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

http://www.wikidata.org/entity/Q27860958

about

Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity PrKX is a novel catalytic subunit of the cAMP-dependent protein kinase regulated by the regulatory subunit type I Chloroform extract of hog barn dust modulates skeletal muscle ryanodine receptor calcium-release channel (RyR1)Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes Identification and characterization of two G protein-coupled receptors for neuropeptide FF Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell protein Pro-urokinase-type plasminogen activator is a substrate for hepsin Selective and ATP-dependent translocation of peptides by the homodimeric ATP binding cassette transporter TAP-like (ABCB9)Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs Galanin pathogenic mutations in temporal lobe epilepsy Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists.Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3delta GABAA receptors Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning Molecular cloning and characterization of the human A3 adenosine receptor.Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac)Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor Microbial ureases: significance, regulation, and molecular characterization Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor SUMO protease SENP1 induces isomerization of the scissile peptide bond Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels

P2860

Q21090765-1E3B1AE3-92ED-4E16-8B02-EC579869E927 Q21133932-E7CFCA71-EF28-41D3-9CC2-AAEFE3179FE5 Q21135310-99ED3F21-869D-4A23-9E55-643E686A8AE5 Q22008785-8D82D30E-A9EF-431E-B016-9F39B9A4A8ED Q23911039-8C3A09D4-44FF-4BD2-9CE5-48D5CE71B08A Q23918788-873CC889-0B46-477C-A34C-08144B5BC636 Q24290374-51199CA9-AF7D-4401-97EF-4DD4EE838FFA Q24297642-698CE188-F23D-49B8-B9C9-2505344E8F36 Q24298076-E338C38F-1FAC-4812-B324-7EBF2DE301B8 Q24299743-045E96B8-1830-40C5-8F12-564AC45F4DE6 Q24301098-72306164-11C1-4F2C-9205-FEA8E647C971 Q24304303-DC023598-ECC9-4514-8057-E0C607EFF852 Q24308751-CF5B1FF9-F23F-4FE5-9CEA-E65D86F590D3 Q24309148-C8082824-9581-4EEA-A8C9-B8B9F65D1815 Q24311776-32A90749-68AF-46B4-AF8D-397134CD7F56 Q24313646-F68282B3-ACA4-4B74-AEB3-82C0FF2F1872 Q24317138-7B987B80-2BD0-4EAF-8554-18B1D26C6355 Q24319705-7F6A2329-1C01-44D7-B64E-8AFBB912F74D Q24321779-5CF7C064-6A1D-40D4-B12F-143A1D88FA37 Q24322039-4C4F94EF-B498-45A2-B9CA-5CBAA2471173 Q24337397-DD9E7DB4-0C37-4B81-B027-9F1227CBD534 Q24338133-12E57BF6-B504-43E5-9AE0-66BA4BD781D9 Q24338360-47B32530-BE6C-46F6-95C2-82F99E7EF40C Q24530005-A16DF2B4-82E6-4F5D-952A-09531F6A75FF Q24534620-56E935A9-12BB-4C35-8A6D-DCF6D7EC9422 Q24535863-476EBA7B-7027-40B9-A7FD-362D9E8DE4E5 Q24548490-E9B38977-4E1E-4F81-B19C-FA8E1985E4A8 Q24553340-01FF9255-8E7D-497B-B19E-9AA0C17B6CF7 Q24561553-0169BB7A-F7BF-4C2F-90E6-B34DD9D3AE74 Q24563274-8B29ECAE-F4FC-44EF-9801-5511FF113FE3 Q24564255-E67FF2FC-1B45-4301-85BF-92F97756C747 Q24564442-737EB6E3-6E0A-40E1-9901-8406333D7CDF Q24564795-6822CF1C-3969-4B30-8563-66F2FAEBDB80 Q24569663-FF0B1D57-AFC3-4ACA-B22B-8DDBFA156EE7 Q24594053-56DC7829-DB4B-4527-8002-20987EC4FE4E Q24594645-29B68B51-82E4-4D6D-9E24-2CAD49D20D5A Q24594844-42B35C95-3926-44EE-8258-6F659322C577 Q24596746-6775603A-5DDE-4E4E-9788-58C04F3FED4B Q24598150-1F723A06-24D1-4F1A-A987-32E0B5D3D5F3 Q24599453-0E0AD868-C824-438B-B9F1-EF4E1D0E8F59

P2860

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

http://www.wikidata.org/entity/Q27860958

description

1973 nî lūn-bûn

@nan

1973 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1973 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1973年の論文

@ja

1973年論文

@yue

1973年論文

@zh-hant

1973年論文

@zh-hk

1973年論文

@zh-mo

1973年論文

@zh-tw

1973年论文

@wuu

name

Relationship between the inhib ...... (I50) of an enzymatic reaction

@ast

Relationship between the inhib ...... (I50) of an enzymatic reaction

@en

Relationship between the inhib ...... (I50) of an enzymatic reaction

@nl

type

label

Relationship between the inhib ...... (I50) of an enzymatic reaction

@ast

Relationship between the inhib ...... (I50) of an enzymatic reaction

@en

Relationship between the inhib ...... (I50) of an enzymatic reaction

@nl

prefLabel

Relationship between the inhib ...... (I50) of an enzymatic reaction

@ast

Relationship between the inhib ...... (I50) of an enzymatic reaction

@en

Relationship between the inhib ...... (I50) of an enzymatic reaction

@nl

P1433

Q27860958-B29CACA3-D123-4EA8-8DFB-B35B78396059

P1476

Q27860958-DD1163FC-2860-429E-A4E7-26F61EB7F0DF

P2093

Q27860958-BB2EB54C-C2D6-4E20-854D-657219C85AE9

Q27860958-F29FAABC-0DCE-4B36-8565-3248B68696A7

P304

Q27860958-E889DEC3-652C-4932-9599-CBAF7B4467A4

P31

Q27860958-210F2447-F841-49E0-958F-E20B928A0CCF

P3181

Q27860958-6F39B5FA-A0B5-4B0D-A86A-FBAA5275D62E

P356

Q27860958-F207A9D2-A381-40E8-BB72-5E0803AC4EEC

P407

Q27860958-1A2A4EB9-74FC-40E4-8115-35B880D93B62

P433

Q27860958-87E94076-79B4-4D79-A4A4-B237965FE783

P478

Q27860958-D1B69A7E-DBA4-40CF-A705-FE47B2BC3855

P577

Q27860958-C1C1098A-AC7A-4389-91BA-CC90EB6C009D

P698

Q27860958-A3AB4C21-B4B2-424C-B7E7-29C2E4754820

P3181

P356

0006-2952(73)90196-2

P1433

Biochemical Pharmacology

P1476

Relationship between the inhib ...... (I50) of an enzymatic reaction

@en

P2093

W H Prusoff

http://www.w3.org/2001/XMLSchema#string

Y Cheng

http://www.w3.org/2001/XMLSchema#string

P304

3099-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

565707

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/0006-2952(73)90196-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

1973-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

4202581

http://www.w3.org/2001/XMLSchema#string